Carlotta Cocchetti
Overview
Explore the profile of Carlotta Cocchetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fisher A, Ristori J, Romani A, Cassioli E, Mazzoli F, Cocchetti C, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(6):1565-1579.
PMID: 38099569
Context: The role of body modifications induced by gonadal suppression in transgender and gender diverse adolescents on psychological functioning has not yet been evaluated. Objective: The main aim of the...
2.
Marconi M, Riitano G, Fisher A, Cocchetti C, Pagano M, Capozzi A, et al.
Clin Exp Immunol
. 2023 Nov;
219(1).
PMID: 37962550
No abstract available.
3.
Cocchetti C, Romani A, Mazzoli F, Ristori J, Lagi F, Meriggiola M, et al.
J Clin Med
. 2022 May;
11(10).
PMID: 35628902
The burden of sexually transmitted infections (STIs) in the transgender population remains an underestimated issue. The aims of the present study were to evaluate the prevalence of either self-reported and...
4.
Cocchetti C, Baldinotti F, Romani A, Ristori J, Mazzoli F, Vignozzi L, et al.
Sex Med
. 2022 May;
10(4):100522.
PMID: 35588601
Introduction: Deficiency of the 17β-hydroxysteroid dehydrogenase type 3 (17 β-HSD3) is a rare autosomal recessive 46,XY Difference of sex development (DSD), resulting from pathogenetic variants in the HSD17B3 gene, which...
5.
Cocchetti C, Romani A, Collet S, Greenman Y, Schreiner T, Wiepjes C, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407392
Literature on the efficacy and safety of gender-affirming hormonal treatment (GAHT) in transgender people is limited. For this reason, in 2010 the European Network for the Investigation of Gender Incongruence...
6.
Dicembrini I, Vitale V, Cosentino C, Cresci B, Pala L, Pieri M, et al.
Acta Diabetol
. 2022 Jan;
59(3):435-438.
PMID: 35088165
No abstract available.
7.
Romani A, Mazzoli F, Ristori J, Cocchetti C, Cassioli E, Castellini G, et al.
J Sex Med
. 2021 Nov;
18(11):1933-1944.
PMID: 34749989
Background: Over the last few years, the gender binary has been questioned, highlighting the existence of gender diverse people, who identify as neither (exclusively) male nor female. Aim: The present...
8.
Cocchetti C, Castellini G, Iacuaniello D, Romani A, Maggi M, Vignozzi L, et al.
J Sex Med
. 2021 Mar;
18(4):821-829.
PMID: 33745831
Background: Cardiovascular (CV) implications of long-term gender affirming hormonal treatment (GAHT) in transgender individuals still remain largely unknown. Aim: To evaluate changes in the 30-year Framingham cardiovascular disease (CVD) risk...
9.
Ristori J, Rossi E, Cocchetti C, Mazzoli F, Castellini G, Vignozzi L, et al.
Int J Impot Res
. 2021 Mar;
33(7):687-693.
PMID: 33727693
Recent studies showed that transgender (TGN) adolescents are more at risk of negative sexual outcomes than their peers. However, little is known about the psychopathological and sociodemographic correlates of sexual-related...
10.
Cocchetti C, Ristori J, Mazzoli F, Vignozzi L, Maggi M, Fisher A
Int J Impot Res
. 2021 Feb;
33(7):703-709.
PMID: 33558671
Hypoactive sexual desire disorder (HSDD) represents a common condition among transgender women. However, to date no specific guidelines for the management of HSDD in transgender persons are available. The aim...